Chemours (CC) Accumulated Expenses (2014 - 2026)

Chemours' Accumulated Expenses history runs 13 years deep, the most recent figure standing at $37.0 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 90.66% year-over-year to $37.0 million in Q1 2026; TTM through Mar 2026 was $37.0 million, a 90.66% decrease from a year earlier, with the FY2025 full-year figure at $506.0 million, up 411.11% from the prior year.
• Accumulated Expenses fell to $37.0 million in Q1 2026 per CC's latest filing, from $506.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.1 billion in Q4 2023 and bottomed at $17.0 million in Q4 2022.
• The 5-year median for Accumulated Expenses is $130.0 million (2022), against an average of $357.3 million.
• Across the five-year window, Accumulated Expenses surged 6129.41% in 2023 and tumbled 92.15% in 2024, its largest moves.
• Year by year, Accumulated Expenses stood at $17.0 million in 2022, then jumped by 6129.41% to $1.1 billion in 2023, then slumped by 90.65% to $99.0 million in 2024, then jumped by 411.11% to $506.0 million in 2025, then sank by 92.69% to $37.0 million in 2026.
• Per Business Quant, the three latest CC Accumulated Expenses figures stand at $37.0 million (Q1 2026), $506.0 million (Q4 2025), and $580.0 million (Q3 2025).